Media reports that Michael Chang, the chairman of the company, Amy Huang, the general manager and the staffs, six people in total, were guaranteed pending summons for alleged insider trading.

Publication of the Breast Cancer Study Abstract to be presented at ASCO 2016
May 19, 2016
The company states the media’s reports on the related matters of American Society of Clinical Oncology (ASCO).
May 29, 2016

1.Date of occurrence of the event:2016/05/26
2.Company name: OBI Pharma, Inc.
3.Relationship to the Company (please enter ”head office” or ”affiliatecompany”): The Company head office
4.Reciprocal shareholding ratios: N/A
5.Name of mass media: N/A
6.Content reported: Due to involvement in insider trading, Zhang Nianci (Michael Chang), the chairman of the company, Huang Xiumei (Amy Huang), the general manager and the staffs, six people in total, were summoned by Shilin District Court Prosecutor’s Office; and in addition to maintaining the original judgement of the chairman Zhang Nianci, the rest of the staff were for guaranteed pending summons.
7.Cause of occurrence: Zhang Nianci (Michael Chang), the chairman of the company, Huang Xiumei (Amy Huang), the general manager and the staffs, six people in total, were guaranteed pending summons for allegedly violating the Securities Exchange Act and other Acts. The Company provided relevant data to cooperate with the prosecution program, and looked forward to clarifying the truth as soon as possible.
8.Countermeasures: None
9.Any other matters that need to be specified: Company operations and financial position all normal.